|
|
穴位贴敷治疗寒凝血瘀型下肢动脉硬化闭塞症的临床观察
|
Abstract:
目的：探讨穴位贴敷治疗寒凝血瘀型下肢动脉硬化闭塞症(ASO)的临床疗效。方法：将2022.06~2023.06就诊于黑龙江中医药大学附属第一医院的72例ASO患者随机分为对照组与治疗组，每组各36例。对照组给予静滴己酮可可碱注射液、血塞通注射液、口服阳和汤加减方治疗，观察组在对照组的基础上合用穴位贴敷治疗，两组均治疗14天，观察治疗前后中医证候、踝肱指数、血脂变化情况，评估临床疗效。结果：两组患者治疗前后比较中医证候评分、血脂指标均降低，且观察组降低幅度明显低于对照组(P < 0.05)；与对照组相比，观察组治疗后踝肱指数显著升高(P < 0.05)；观察组总有效率为91.67% (44/48)，对照组总有效率为77.08% (37/48)，两组总有效率比较，差异有统计学意义(P < 0.05)。结论：穴位贴敷治疗有效地改善ASO患者的临床症状和体征，改善患者下肢缺血情况，且其操作便捷，患者依从性较高，值得在临床大力推广使用。
Objective: To investigate the clinical efficacy of acupoint application in treating lower limb arterial occlusive disease of the cold coagulation and blood stasis type. Methods: During the period from June 2022 to June 2023, a total of seventy-two patients diagnosed with ASO visited the First Hospital Affiliated to Heilongjiang University of Traditional Chinese Medicine. They were randomly allocated into two groups: the control group and the treatment group, each consisting of 36 patients. The control group received treatment through intravenous injection of pentoxifylline, hemosiderin injection, and oral Yanghe Tang plus and minus formula. On the other hand, the treatment group underwent acupoint patch therapy in addition to the control group's treatment regimen. Both groups underwent a 14-day treatment course, and changes in Chinese medicine symptoms, ankle-brachial index, and blood lipids were monitored before and after treatment to assess the clinical effectiveness. Results: Both before and after treatment, the lipid indicators in the two groups of patients showed a decrease according to the Chinese medicine evidence score, with the observation group showing a significantly greater reduction than the control group (P < 0.05). After treatment, the observation group exhibited a significant increase in the ankle-brachial index compared to the control group (P < 0.05). The total effective rate was 91.67% (44/48) in the observation group and 77.08% (37/48) in the control group, and the difference between the two groups was statistically significant (P < 0.05). Conclusion: Acupoint application effectively improves the clinical symptoms and signs of patients with lower limb arterial occlusive disease, improves lower limb ischemia, and has the advantages of convenience and high patient compliance. It is worth promoting its use in clinical practice.
| [1] | 邓俊林, 曹芳, 王御震, 等. 1992-2022年中医药治疗下肢动脉硬化闭塞症研究文献可视化分析[J]. 中国中医药信息杂志, 2024, 31(2): 70-77. |
| [2] | 刘昌伟. 下肢动脉硬化性闭塞症治疗指南[J]. 中国实用外科杂志, 2008, 28(11): 923-924. |
| [3] | 庄金满, 李选. 下肢动脉硬化闭塞症的治疗进展[J]. 中国微创外科杂志, 2014(9): 839-843. |
| [4] | 徐义岩, 王海洋. 下肢动脉硬化闭塞症的治疗进展[J]. 医学综述, 2020, 26(24): 4892-4895. |
| [5] | 张玉镇, 周发祥. 崔公让教授对脱疽外科处理原则及方法的继承与创新[J]. 中医学报, 2013, 28(5): 669-671. |
| [6] | 中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华普通外科学文献(电子版), 2016, 10(1): 1-18. |
| [7] | 王海红, 郑学军. 动脉二号加减方治疗下肢动脉硬化闭塞症的疗效及对血液流变学的影响[J]. 中药材, 2023(11): 2870-2875. |
| [8] | Norgren, L., Hiatt, W.R., Dormandy, J.A., et al. (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery, 45, S5-S67. https://doi.org/10.1016/j.jvs.2006.12.037 |
| [9] | 崔公让, 谭鸿雁. 动脉硬化闭塞症[M]. 北京: 人民军医出版社, 2000. |
| [10] | 中国中西医结合学会周围血管病专业委员会. 动脉硬化闭塞症诊断及疗效标准(2016年修订稿) [J]. 北京中医药, 2016, 35(10): 909-910. |
| [11] | 陶军. 重视外周动脉疾病的临床诊治[J]. 中华老年心脑血管病杂志, 2012, 14(12): 1233-1234. |
| [12] | Olin, J.W., Cressman, M.D., Young, J.R., et al. (1992) Lipid and Lipoprotein Abnormalities in Lower-Extremity Arteriosclerosis Obliterans. Cleveland Clinic Journal of Medicine, 59, 491-497. |
| [13] | Selvin, E. and Erlinger, T.P. (2004) Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation, 110, 738-743. https://doi.org/10.1161/01.CIR.0000137913.26087.F0 |
| [14] | 陈玲婷, 王荩, 彭飞, 等. 下肢动脉硬化性闭塞症发病机制的研究进展[J]. 心理月刊, 2018(12): 111. |
| [15] | 郭伟光, 赵鸿儒, 王景. 中医药治疗动脉硬化闭塞症的研究进展[J]. 中医药学报, 2020, 48(10): 75-79. |
| [16] | 陆爽爽, 刘遵, 史伟浩, 等. 下肢动脉硬化闭塞症患者腔内治疗术后运动及患侧肢体侧支血管的现况调查[J]. 中国医学计算机成像杂志, 2023, 29(2): 191-195. |
| [17] | 王巧萍, 黄学阳. 脱疽的古文献综述[J]. 中医研究, 2004, 17(1): 57-60. |
| [18] | 孙旭, 张立民. 下肢动脉硬化闭塞症的中医认识[J]. 安徽中医药大学学报, 2017, 36(6): 8-10. |
| [19] | 崔向武, 刘洁, 何婷婷, 等. 中医治疗下肢动脉硬化闭塞症研究进展[J]. 广西医学, 2019, 41(23): 3045-3048. |
| [20] | 侯俊杰, 李大勇, 李世征, 等. 加味阳和汤治疗寒凝血瘀证下肢动脉硬化闭塞症的临床疗效及对血清ET-1、NO水平变化的影响[J]. 中华中医药学刊, 2019, 37(9): 2093-2097. |
| [21] | 贺艳萍, 肖小芹, 邓桂明, 等. 中药穴位贴敷作用机理研究概况[J]. 中国中医药信息杂志, 2017, 24(3): 134-136. |
| [22] | 周培娟, 王乐, 王爱成, 等. 针刺治疗下肢动脉硬化闭塞症取穴规律分析[J]. 河南中医, 2015, 35(3): 620-622. |
| [23] | 刘显峰, 郭娴, 关擘, 等. 温和灸治疗阳虚寒凝型动脉硬化性闭塞症的临床疗效观察[J]. 中国中医基础医学杂志, 2013, 19(10): 1176-1177. |
| [24] | 李思慧, 刘书庆, 王玥梅, 等. 阳陵泉穴功效主治及生物学机制研究进展[J]. 按摩与康复医学, 2023, 14(4): 56-59. |
| [25] | 陈小丽, 岳增辉, 刘丽, 等. 足三里穴的古今应用与研究[J]. 针灸临床杂志, 2016, 32(7): 80-83. |
| [26] | 贾雪梅, 陈敬欢, 郑梅兰. 针灸治疗高血压46例的疗效观察[J]. 齐齐哈尔医学院学报, 2012, 33(11): 1472-1473. |
| [27] | 郭晓乐, 刘晓娜, 王富春. 三阴交穴的临床应用与机理研究[J]. 吉林中医药, 2011, 31(1): 47-48. |
| [28] | 沈群, 王波, 金春蕾. 吴茱萸穴位贴敷涌泉穴治疗失眠的研究进展[J]. 环球中医药, 2013(z2): 48-49. |
| [29] | 白白. 涌泉穴临床应用概况[J]. 实用中医药杂志, 2012, 28(7): 614-615. |
| [30] | 李芊, 吴效科. 川芎化学成分及药理作用研究新进展[J]. 化学工程师, 2020, 34(1): 62-64, 44. |
| [31] | 吴建华, 鞠振国, 王轶, 等. 通脉穴贴膏治疗下肢动脉硬化闭塞症的临床观察[J]. 中医药导报, 2018, 24(5): 95-98. |
| [32] | 袁蓉, 陈敏, 信琪琪, 等. 川芎嗪对动脉粥样硬化小鼠血管新生的影响[C]//中华中医药学会. 第十届全国中医药博士生学术论坛论文集: 2019年卷. 2019: 2250-2254. |
| [33] | 孙凤娇, 李振麟, 钱士辉, 等. 干姜化学成分和药理作用研究进展[J]. 中国野生植物资源, 2015, 34(3): 34-37. |
| [34] | 梁辉, 赵镭, 杨静, 等. 花椒化学成分及药理作用的研究进展[J]. 华西药学杂志, 2014, 29(1): 91-94. |
| [35] | 韩婷, 宓鹤鸣. 姜黄的化学成分及药理活性研究进展[J]. 解放军药学学报, 2001, 17(2): 95-97. |
| [36] | 魏华, 彭勇, 马国需, 等. 木香有效成分及药理作用研究进展[J]. 中草药, 2012, 43(3): 613-620. |
| [37] | 陈旭, 刘畅, 马宁辉, 等. 肉桂的化学成分、药理作用及综合应用研究进展[J]. 中国药房, 2018, 29(18): 2581-2584. |
| [38] | 龚慕辛, 王智民, 张启伟, 等. 吴茱萸有效成分的药理研究进展[J]. 中药新药与临床药理, 2009, 20(2): 183-187. |
| [39] | 王金金, 毋启桐, 时博, 等. 小茴香炮制历史沿革、化学成分及药理作用研究进展[J]. 中国实验方剂学杂志, 2020, 26(20): 178-190. |
| [40] | 刘月, 刘金波, 刘欢, 等. 血管危险因素、踝肱指数与下肢动脉硬化闭塞症患者合并慢性静脉功能不全的相关性分析[J]. 心血管病学进展, 2022, 43(6): 554-558. |
| [41] | 张静, 葛建立, 张欣, 等. 芪黄疽愈方对ASOLE大鼠肝脏脂质代谢相关因子表达的影响[J]. 中国中医基础医学杂志, 2020, 26(12): 1784-1786, 1869. |
| [42] | 吴庆华. 下肢动脉硬化闭塞症药物治疗及评价[J]. 中国实用外科杂志, 2016, 36(12): 1256-1259. |
